Circulating bile acids concentration is predictive of coronary artery disease in human

Abstract Synthetized by the liver and metabolized by the gut microbiota, BA are involved in metabolic liver diseases that are associated with cardiovascular disorders. Animal models of atheroma documented a powerful anti-atherosclerotic effect of bile acids (BA). This prospective study examined whet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caroline Chong Nguyen, Denis Duboc, Dominique Rainteau, Harry Sokol, Lydie Humbert, Philippe Seksik, Adèle Bellino, Hendy Abdoul, Naïm Bouazza, Jean-Marc Treluyer, Malika Saadi, Karim Wahbi, Heithem Soliman, Benoit Coffin, André Bado, Maude Le Gall, Olivier Varenne, Henri Duboc
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1c4ea355bf004c9ebc1162d31405978c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c4ea355bf004c9ebc1162d31405978c
record_format dspace
spelling oai:doaj.org-article:1c4ea355bf004c9ebc1162d31405978c2021-11-28T12:21:39ZCirculating bile acids concentration is predictive of coronary artery disease in human10.1038/s41598-021-02144-y2045-2322https://doaj.org/article/1c4ea355bf004c9ebc1162d31405978c2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02144-yhttps://doaj.org/toc/2045-2322Abstract Synthetized by the liver and metabolized by the gut microbiota, BA are involved in metabolic liver diseases that are associated with cardiovascular disorders. Animal models of atheroma documented a powerful anti-atherosclerotic effect of bile acids (BA). This prospective study examined whether variations in circulating BA are predictive of coronary artery disease (CAD) in human. Consecutive patients undergoing coronary angiography were enrolled. Circulating and fecal BA were measured by high pressure liquid chromatography and tandem mass spectrometry. Of 406 screened patients, 80 were prospectively included and divided in two groups with (n = 45) and without (n = 35) CAD. The mean serum concentration of total BA was twice lower in patients with, versus without CAD (P = 0.005). Adjusted for gender and age, this decrease was an independent predictor of CAD. In a subgroup of 17 patients, statin therapy doubled the serum BA concentration. Decreased serum concentrations of BA were predictors of CAD in humans. A subgroup analysis showed a possible correction by statins. With respect to the anti-atherosclerotic effect of BA in animal models, and their role in human lipid metabolism, this study describe a new metabolic disturbance associated to CAD in human.Caroline Chong NguyenDenis DubocDominique RainteauHarry SokolLydie HumbertPhilippe SeksikAdèle BellinoHendy AbdoulNaïm BouazzaJean-Marc TreluyerMalika SaadiKarim WahbiHeithem SolimanBenoit CoffinAndré BadoMaude Le GallOlivier VarenneHenri DubocNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Caroline Chong Nguyen
Denis Duboc
Dominique Rainteau
Harry Sokol
Lydie Humbert
Philippe Seksik
Adèle Bellino
Hendy Abdoul
Naïm Bouazza
Jean-Marc Treluyer
Malika Saadi
Karim Wahbi
Heithem Soliman
Benoit Coffin
André Bado
Maude Le Gall
Olivier Varenne
Henri Duboc
Circulating bile acids concentration is predictive of coronary artery disease in human
description Abstract Synthetized by the liver and metabolized by the gut microbiota, BA are involved in metabolic liver diseases that are associated with cardiovascular disorders. Animal models of atheroma documented a powerful anti-atherosclerotic effect of bile acids (BA). This prospective study examined whether variations in circulating BA are predictive of coronary artery disease (CAD) in human. Consecutive patients undergoing coronary angiography were enrolled. Circulating and fecal BA were measured by high pressure liquid chromatography and tandem mass spectrometry. Of 406 screened patients, 80 were prospectively included and divided in two groups with (n = 45) and without (n = 35) CAD. The mean serum concentration of total BA was twice lower in patients with, versus without CAD (P = 0.005). Adjusted for gender and age, this decrease was an independent predictor of CAD. In a subgroup of 17 patients, statin therapy doubled the serum BA concentration. Decreased serum concentrations of BA were predictors of CAD in humans. A subgroup analysis showed a possible correction by statins. With respect to the anti-atherosclerotic effect of BA in animal models, and their role in human lipid metabolism, this study describe a new metabolic disturbance associated to CAD in human.
format article
author Caroline Chong Nguyen
Denis Duboc
Dominique Rainteau
Harry Sokol
Lydie Humbert
Philippe Seksik
Adèle Bellino
Hendy Abdoul
Naïm Bouazza
Jean-Marc Treluyer
Malika Saadi
Karim Wahbi
Heithem Soliman
Benoit Coffin
André Bado
Maude Le Gall
Olivier Varenne
Henri Duboc
author_facet Caroline Chong Nguyen
Denis Duboc
Dominique Rainteau
Harry Sokol
Lydie Humbert
Philippe Seksik
Adèle Bellino
Hendy Abdoul
Naïm Bouazza
Jean-Marc Treluyer
Malika Saadi
Karim Wahbi
Heithem Soliman
Benoit Coffin
André Bado
Maude Le Gall
Olivier Varenne
Henri Duboc
author_sort Caroline Chong Nguyen
title Circulating bile acids concentration is predictive of coronary artery disease in human
title_short Circulating bile acids concentration is predictive of coronary artery disease in human
title_full Circulating bile acids concentration is predictive of coronary artery disease in human
title_fullStr Circulating bile acids concentration is predictive of coronary artery disease in human
title_full_unstemmed Circulating bile acids concentration is predictive of coronary artery disease in human
title_sort circulating bile acids concentration is predictive of coronary artery disease in human
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1c4ea355bf004c9ebc1162d31405978c
work_keys_str_mv AT carolinechongnguyen circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT denisduboc circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT dominiquerainteau circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT harrysokol circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT lydiehumbert circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT philippeseksik circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT adelebellino circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT hendyabdoul circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT naimbouazza circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT jeanmarctreluyer circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT malikasaadi circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT karimwahbi circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT heithemsoliman circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT benoitcoffin circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT andrebado circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT maudelegall circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT oliviervarenne circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
AT henriduboc circulatingbileacidsconcentrationispredictiveofcoronaryarterydiseaseinhuman
_version_ 1718407999078268928